Hosted on MSN1mon
FDA fast tracks Bracco’s BR55 for Crohn’s disease bowel inflammation detection
The US Food and Drug Administration (FDA) has granted fast track designation for the development of Bracco Imaging's molecular imaging ultrasound contrast agent, BR55, to identify active bowel ...
Nature4y
Bracco’s technology and leadership improves cardiac disease diagnosis and mangement
Bracco Diagnostics is a leader in cardiac PET, and its premier solutions have become essential tools for physicians making treatment decisions for cardiac disease. Since its launch in 1989 ...